News Focus
News Focus
Followers 45
Posts 1535
Boards Moderated 0
Alias Born 11/25/2013

Re: None

Thursday, 06/24/2021 7:54:46 PM

Thursday, June 24, 2021 7:54:46 PM

Post# of 447325
Another clinical trial of 1
My cousin has dermatomyositis- her immune system is attacking her muscle and skin. She takes prednisone, hydroxychloroquin, methotrexate, imuran - you name it to suppress her immune system. For the last 5 years I have been telling her to take EPA and she finally started OmegaVia EPA 500 at 4gm/day about 5 months ago. Today she texted me in a panic - the Canadian supplier of OmegaVia is out of stock and has been for a while and she desperately looking for another source. She tried to get her rheumatologist to prescribe V but she wouldn’t (no evidence, and she is right). My cousin said she is doing the best she has ever felt in 5 years since starting EPA, her prednisone dose is down to only 2mg/day (lowest previously was 10mg) and her CK levels are normal. Rheumatologist still won’t prescribe V.
One more example of how V (or at least a cheap imitation of V) restores balance to the immune system. Autoimmune diseases are a whole new category of therapies. Therapies that won’t be researched without patents being able to protect the investment. Sad.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News